Bingzhi Zhang, Ph.D.

Affiliations: 
2013 Biostatistics Columbia University, New York, NY 
Area:
BIOSTATISTICAL METHODS, EDUCATION, GLOBAL HEALTH
Google:
"Bingzhi Zhang"

Parents

Sign in to add mentor
Bin Cheng grad student 2013 Columbia
 (On Compositional Data Modeling and Its Biomedical Applications.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Cheng B, Zhang B, Chow SC. (2020) Unified approaches to assessing treatment effect of traditional Chinese medicine based on health profiles. Journal of Biopharmaceutical Statistics. 1-10
Castro M, Rabe KF, Corren J, et al. (2020) Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma. Erj Open Research. 6
Castro M, Corren J, Pavord ID, et al. (2018) Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma. The New England Journal of Medicine
Busse WW, Maspero JF, Rabe KF, et al. (2018) Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma. Advances in Therapy
Busse W, Maspero JF, Katelaris CH, et al. (2018) Dupilumab improves SNOT-22 scores in asthma patients with chronic rhinosinusitis or nasal polypsosis (CRS/NP) in LIBERTY ASTHMA QUEST European Respiratory Journal. 52
Wenzel S, Swanson B, Teper A, et al. (2016) Dupilumab reduces severe exacerbations in periostin-high and periostin-low asthma patients European Respiratory Journal. 48
Huang ZY, Cheng BJ, Cai GJ, et al. (2015) Association of the IL-4R Q576R polymorphism and asthma in the Chinese Han population: a meta-analysis. Genetics and Molecular Research : Gmr. 14: 2900-11
Wenzel S, Castro M, Zhang B, et al. (2015) LATE-BREAKING ABSTRACT: A dose-ranging study of dupilumab in patients (pts) with uncontrolled asthma despite use of inhaled corticosteroids plus a long-acting beta-agonist (ICS/LABA): Final data European Respiratory Journal. 46
See more...